NIFTY
80.75  0.75%
 10821.85
S&P BSE SENSEX
257.21  0.73%
 35689.6
Sun Pharmaceutical Industries Ltd.
NSE : SUNPHARMA BSE : 524715 ISIN code : INE044A01036
on 22-Jun-2018 15:54
NSE
22.75    4.1%
Rs. 577.25
 
Days Low
Rs. 548
Days High
Rs. 580

Open Rs. 551
 
52 week Low
Rs. 433.15
52 week High
Rs.608.55
 
 
Bid :                 576.30 (3032)
Offer :        0.00 (0)
BSE
Rs.576.30
21.7    3.91%
on 22-Jun-2018 15:54
BSE
21.7    3.91%
Rs. 576.30
 
Days Low
Rs. 547.65
Days High
Rs. 581.8

Open Rs. 553
 
52 week Low
Rs. 432.7
52 week High
Rs.608.95
 
 
Bid :                 576.30 (3032)
Offer :        0.00 (0)
NSE
Rs.577.25
22.75    4.1%
 
 
Last Price (Rs.)  576.30 Value  498364645.80
Net Change (Rs.)  21.70 Best Buy  576.30
Volume  864766 Best Sell  0.00
Prev.Close (Rs.)  554.60 Best Quantity  3032
Open (Rs.)  551.00 Sell Quantity  0
High (Rs.)  580.00 52-Week High (Rs.)  608.55
Low (Rs.)  548.00 52-Week Low (Rs.)  433.15
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  1382730.71
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Share Capital2399.30 2406.60 2071.20 
Currents Investments400.10 735.60 939.30 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Cipla 614.00 494387 175.28 50.67 0.49
Piramal Enterprises 2602.35 469965 1186.24 57.81 0.96
Cadila Healthcare 410.55 420298 75.66 63.51 0.85
Lupin 904.90 409126 349.13 13.01 0.55
Dr. Reddys Lab 2334.95 387539 711.43 27.97 0.86
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2018Dec 2017Sep 2017
Net Sales22831.8020452.3018238.40
Operating Profit3731.102117.908082.90
PBDT2625.201470.906787.10
Net Profit1762.60405.005770.50
More> 
 
Company News
6/14/2018 12:00:00 AM
Sun Pharma trades higher on the bourses
6/13/2018 12:00:00 AM
Sun Pharma receives EIR from USFDA for inspection at Halol facility
6/13/2018 12:00:00 AM
Sun Pharma spurts on receiving EIR from USFDA for inspection at Halol ...
More>
 
Ratios
   Earnings Per Share (Rs)-0.15 
   Book NAV/Share(Rs)86.98 
   PAT Margin (%)-0.45 
   Asset Turnover(x)0.23 
   PER(x)0.00 
   Yield(%)0.51 
   EV/Core EBITDA(x)280.28 
   M Cap / Sales21.44 
   Net Sales Growth(%)-0.46 
   PAT Growth(%)96.79 
   Total Debt/Equity(x)0.29 
   Current Ratio(x)0.58 
   Quick Ratio(x)0.37 
   Total Debt/Mcap(x)0.04 
More>